Feb. 21, 2025
| Today’s news and insights for medtech leaders
Interim CEO Brent Shafer said the medical products maker is ready to begin a new era after several years of “heavy lifting” to simplify the business structure.
|
"Any place that gets cut, it's going to have an impact, because there's not any spare personnel at FDA,” said former agency commissioner Robert Califf.
|
Expanding parts inventory and logistics capabilities will support later cutoff times, same-day delivery within 300 miles and more next-flight-out options for customers, the company said.
|
The new year brings potential for change in the manufacturing sector, from the impacts of a new administration’s policy proposals to the uptake of emerging tech like generative AI. Explore what to expect in
|
The cuts at the FDA’s device center could add “months, if not years” to the time it takes to bring products to market, an attorney said.
|
Scott Whitaker sent a letter to the HHS calling for staff cuts at the FDA to be reversed, arguing patient care and U.S. leadership in medtech are on the line.
|
From Our Library
Webinar - on demand
Custom content for RRD
|
Playbook
Custom content for ORO Labs
|
View all resources
What We're Reading
Reuters
|
The Wall Street Journal
|
KFF Health News
|
|